Julie Frearson, PhD, Charles River Laboratories

Professor Frearson leads Charles River’s effort in developing and managing strategic venture fund and innovation technology partnerships across the company’s business units. Prior to joining Charles River, Professor Frearson built substantial experience in early-stage drug discovery through roles with Zeneca, The Babraham Institute, Cambridge Drug Discovery, BioFocus, and a faculty position in the Drug Discovery Unit of the University of Dundee. Professor Frearson has served as the Director for Scottish Universities Life Sciences Alliance (SULSA) and on funding committees for the Medical Research Council, The Wellcome Trust, Novo Foundation BioInnovation Institute and regional BIO industry groups. Professor Frearson currently sits on multiple private and not-for-profit boards in the life sciences tools and drug development arena across the UK and US.

Professor Frearson received a Ph.D. in Biochemistry from King’s College London, University of London and has authored more than 60 peer-reviewed publications.